CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone before.

British Journal of Haematology
Guido GhilardiMarco Ruella

Abstract

Chimeric antigen receptor (CAR) T cells (CART) therapies have changed and continue to change the treatment paradigms for B-cell malignancies because they can achieve durable complete remission in patients in whom multiple lines of treatment have failed. These unprecedented results have led to the widespread use of anti-CD19 CART therapy for patients with relapsed and refractory aggressive large B-cell lymphomas. While long-term follow-up data show that about one-third of patients achieve prolonged complete remission and are potentially cured, the majority of patients either do not respond to CD19 CART therapy or eventually relapse after CD19 CART therapy. These results are, on the one hand, driving intense research into identifying mechanisms of relapse and, on the other hand, inspiring the development of novel strategies to overcome resistance. This review summarizes current clinical outcomes of CART immunotherapy in B-cell non-Hodgkin lymphomas, describes the most up-to-date understanding of mechanisms of relapse and discusses novel strategies to address resistance to CART therapy. We are indeed at the beginning of a scientific trek to explore the mechanisms of resistance, seek out new, more effective treatment approaches bas...Continue Reading

References

Jun 9, 2001·Applied Immunohistochemistry & Molecular Morphology : AIMM·P G Chu, D A Arber
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia MontotoT Andrew Lister
Jul 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtNorbert Schmitz
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Dec 14, 2011·Hematology·Jonathan W Friedberg
Nov 26, 2013·Frontiers in Immunology·Markus ChmielewskiHinrich Abken
Dec 18, 2013·Immunological Reviews·Marco Ruella, Michael Kalos
Dec 20, 2013·Oncoimmunology·Liza B JohnPhillip K Darcy
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Jan 15, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kevin J CurranRenier J Brentjens
Jun 19, 2015·British Journal of Haematology·Andrew G EvansJane L Liesveld
Jul 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carla CasuloJonathan W Friedberg
Jul 2, 2015·Nature Reviews. Drug Discovery·Sjoukje J C van der StegenMichel Sadelain
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi
Sep 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
Jan 29, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco RuellaMariusz A Wasik
Apr 26, 2016·The Journal of Clinical Investigation·Cameron J TurtleDavid G Maloney
Jul 28, 2016·The Journal of Clinical Investigation·Leonid CherkasskyPrasad S Adusumilli
Aug 1, 2016·Current Hematologic Malignancy Reports·Marco Ruella, Carl H June
Aug 30, 2016·The Journal of Clinical Investigation·Marco RuellaSaar Gill
Oct 21, 2016·Computational and Structural Biotechnology Journal·Marco Ruella, Marcela V Maus
Nov 7, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jiangtao RenYangbing Zhao
Jan 25, 2017·Nature Reviews. Clinical Oncology·Alberto MantovaniPaola Allavena
Feb 16, 2017·Oncotarget·Jiangtao RenYangbing Zhao
Apr 21, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine ThieblemontBertrand Coiffier
May 19, 2017·Journal for Immunotherapy of Cancer·Dina SchneiderRimas J Orentas
Jun 13, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andras HeczeyMalcolm K Brenner
Jul 18, 2017·The Journal of Clinical Investigation·Meixiao LongJohn C Byrd
Aug 16, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Leah AlabanzaJames N Kochenderfer

❮ Previous
Next ❯

Citations

Feb 19, 2021·The Journal of Experimental Medicine·Puneeth GuruprasadMarco Ruella

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.